source
- Lilly adds $870M to Gate Bioscience partnership to pursue new drug targetsEli Lilly is expanding its collaboration with Gate Bioscience, adding a new financial commitment of more than $870 million. The original July 2025 agreement gave Lilly access to Gate’s "Molecular…
- AI drives faster drug development and reshapes biopharma manufacturing facilitiesAI is speeding up the identification of drug candidates, turning years of laboratory work into months by analyzing large biological datasets and accelerating early‑stage development. This accelera…